1. "Finding NEMO" in NRAS-mutant melanoma: a step towards a sequential strategy?. Issue 6 (June 2017) Authors: Bersanelli, Melissa; Leonetti, Alessandro; Buti, Sebastiano; Michiara, Maria Journal: Lancet oncology Issue: Volume 18:Issue 6(2017:Jun.) Page Start: e298 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A metanalysis on cabozantinib and bone metastases: true story or commercial gimmick?. Issue 3 (March 2020) Authors: Bersanelli, Melissa; Buti, Sebastiano; Ghidini, Antonio; Tiseo, Marcello; Petrelli, Fausto Journal: Anti-cancer drugs Issue: Volume 31:Issue 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable. Issue 1 (27th February 2019) Authors: Cortellini, Alessio; Bersanelli, Melissa; Buti, Sebastiano; Cannita, Katia; Santini, Daniele; Perrone, Fabiana; Giusti, Raffaele; Tiseo, Marcello; Michiara, Maria; Di Marino, Pietro; Tinari, Nicola; De Tursi, Michele; Zoratto, Federica; Veltri, Enzo; Marconcini, Riccardo; Malorgio, Francesco; Rus... Journal: Journal for immunotherapy of cancer Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. An Italian, multicenter, real-world, retrospective study of first-line pazopanib in unselected metastatic renal-cell carcinoma patients: the 'Pamerit' study. (20th November 2020) Authors: Mosca, Alessandra; De Giorgi, Ugo; Procopio, Giuseppe; Basso, Umberto; Cartenì, Giacomo; Bersanelli, Melissa; Naglieri, Emanuele; Galli, Luca; Caffo, Orazio; Fornarini, Giuseppe; Boccardo, Francesco; Porta, Camillo Journal: Japanese journal of clinical oncology Issue: Volume 51:Number 3(2021) Page Start: 484 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Anaplastic lymphoma kinase as a new target for the treatment of non-small-cell lung cancer. Issue 11 (November 2011) Authors: Tiseo, Marcello; Gelsomino, Francesco; Bartolotti, Marco; Bordi, Paola; Bersanelli, Melissa; Rossi, Giulio; Ardizzoni, Andrea Journal: Expert review of anticancer therapy Issue: Volume 11:Issue 11(2011) Page Start: 1677 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Another side of the association between body mass index (BMI) and clinical outcomes of cancer patients receiving programmed cell death protein-1 (PD-1)/ Programmed cell death-ligand 1 (PD-L1) checkpoint inhibitors: A multicentre analysis of immune-related adverse events. (March 2020) Authors: Cortellini, Alessio; Bersanelli, Melissa; Santini, Daniele; Buti, Sebastiano; Tiseo, Marcello; Cannita, Katia; Perrone, Fabiana; Giusti, Raffaele; De Tursi, Michele; Zoratto, Federica; Marconcini, Riccardo; Russano, Marco; Zeppola, Tea; Anesi, Cecilia; Filetti, Marco; Marchetti, Paolo; Botticelli... Journal: European journal of cancer Issue: Volume 128(2020) Page Start: 17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Anti-PD1 antibodies in patients aged ≥ 75 years with metastatic melanoma: A retrospective multicentre study. Issue 3 (April 2020) Authors: Ridolfi, Laura; De Rosa, Francesco; Petracci, Elisabetta; Tanda, Enrica Teresa; Marra, Elena; Pigozzo, Jacopo; Marconcini, Riccardo; Guida, Michele; Cappellini, Gian Carlo Antonini; Gallizzi, Giulia; Occelli, Marcella; Pala, Laura; Gambale, Elisabetta; Bersanelli, Melissa; Galdo, Giovanna; Cortel... Journal: Journal of geriatric oncology Issue: Volume 11:Issue 3(2020) Page Start: 515 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Antiangiogenic tyrosine kinase inhibitors and immunotherapy as first-line treatment for metastatic renal cell carcinoma: is there an increased risk of hypothyroidism?. (July 2021) Authors: Roviello, Giandomenico; Buti, Sebastiano; Cattrini, Carlo; Mennitto, Alessia; Messina, Carlo; Airoldi, Chiara; Vannini, Gianmarco; Bersanelli, Melissa Journal: Therapeutic advances in urology Issue: Volume 13(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Antibiotic-dependent effect of probiotics in patients with non-small cell lung cancer treated with PD-1 checkpoint blockade. (September 2022) Authors: Takada, Kazuki; Buti, Sebastiano; Bersanelli, Melissa; Shimokawa, Mototsugu; Takamori, Shinkichi; Matsubara, Taichi; Takenaka, Tomoyoshi; Okamoto, Tatsuro; Hamatake, Motoharu; Tsuchiya-Kawano, Yuko; Otsubo, Kohei; Nakanishi, Yoichi; Okamoto, Isamu; Pinato, David J.; Cortellini, Alessio; Yoshizumi... Journal: European journal of cancer Issue: Volume 172(2022) Page Start: 199 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Cabozantinib in metastatic renal cell carcinoma: latest findings and clinical potential. (October 2017) Authors: Bersanelli, Melissa; Buti, Sebastiano Journal: Therapeutic advances in medical oncology Issue: Volume 9:Number 10(2017) Page Start: 627 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗